REJECTION OF ASCITES TUMOR ALLOGRAFTS : I. ISOLATION, CHARACTERIZATION, AND IN VITRO REACTIVITY OF PERITONEAL LYMPHOID EFFECTOR CELLS FROM BALB/c MICE IMMUNE TO EL4 LEUKOSIS by Berke, Gideon et al.
REJECTION OF  ASCITES TUMOR  ALLOGRAFTS 
I.  ISOLATION, CHARACTERIZATION,  AND  IN  VITRO REACTIVITY OF 
PERITONEAL LYMPHOID E~FECI'OR CELLS FROM BALB/c 
MICE  IMMUNE  TO  EL4  LEUKOSIS* 
BY  GIDEON  BERKE,~  KAREN  A.  SULLIVAN,  AND  BERNARD  AMOS 
(From the Division o[ Immunology, Duke University  Medical  Center, Durham, 
North Carolina 27710) 
(Received for publication 16 February 1972) 
Ascites tumors grow exponentially in the peritoneal cavity of syngeneic mice 
(1). They also proliferate freely for a number of days in allogeneic mice before 
they are rejected.  The rejection of an  ascites tumor by an incompatible host 
affords a  model for the  study of homograft reactivity in  which vascular  and 
stromal effects are minimal (2). One of the most striking features of the reaction 
is  the  sudden  transition  from exponential  growth  to  cataclysmic decline,  oc- 
curring  as it  does within  the  span  of less  than  24  hr  (3).  The  cause for this 
abrupt  fall  in  tumor  cell  number  is  not  clearly understood.  Since  antibody- 
mediated reactions are characteristically rapid, we have previously sought evi- 
dence that the rejection of ascites tumors is due to the effects of antibody (4). 
These attempts have been only partially successful. It is known, however, that 
peritoneal exudate cells (PEC) 1 tend to accumulate during ascites tumor growth 
(3),  and  that host  cells present in  the  ascites fluid have demonstrable  effects 
in both transfer and in vitro test situations (5-7). We have, therefore, attempted 
to identify the most active subpopulation of cells in the peritoneal exudate and 
to investigate its cytotoxic effects in vitro. Results of the present investigations 
suggest that it is possible to isolate from BALB/c mice the population of lymph- 
oid  effector  cells  intimately  associated  with  the  rejection  of  EL4  ascites 
leukemia. 
Materials and Methods 
Animals  and  Immunization.--3-6-month-old  mice of  the  following strains  were used: 
BALB/e  Cr,  C57BL/Spr, and  DBA/2 Ha males (Roswell Park  Memorial Institute,  West 
* Supported by US Public Health Service Research Grants KO-AI18399, SO4-RR06148, 
and  TO1-AI00285. 
1: On leave of absence from the Weizmann Institute  of Science, Rehovot, Israel. 
1  Abbreviations used in this paper: MEM,  minimum essential medium; PBS, phosphate- 
buffered saline; PBS-FCS, PBS supplemented with  10% heat-inactivated  fetal calf serum; 
PEC,  peritoneal exudate cells; RPMI,  RPMI  1640 plus 10% heat-inactivated  ECS, 100 
units/ml penicillin, and 100 #g/ml streptomycin. 
1334  THE  JOURNAL OF  EXPERIMENTAL MEDICINE - VOLUTffE 135,  1972 GIDEON  BERKE~  KAREN  A.  SULLIVAN~ AND  BERNARD  AMOS  1335 
Seneca,  N.  Y.);  male  BALB/cJ,  female  A/J  and  C57BL/6J  (Jackson Laboratories,  Bar 
Harbor, Maine). Mice were immunized against allogeneic tumors by a  single intraperitoneal 
injection of 3 X  107 tumor cells suspended in phosphate-buffered saline (PBS) 2 (8). Peritoneal 
exudate cells or other lymphoid cells were harvested 10-11 days later; the tumor was rejected 
by the 10th day. 
Tumors.--EIA leukemia of C57BL, SaI spindle cell sarcoma  of A/J,  and L1210 leukemia 
of DBA/2 were carried as ascites in the appropriate strains. 
Media.--Immune lymphoid cells or tumor target ceils were collected in PBS supplemented 
with 10% heat-inactivated fetal calf serum  (PBS-FCS),  washed, and resuspended in either 
PBS-FCS  or in RPMI  1540  supplemented with  10% heat-inactivated FCS,  penicillin, 100 
units/ml, and streptomycin, 100 gg/ml (RPMI). 
Cell Preparation.--Animals were killed by CO2 narcosis. Cells were harvested in the cold, 
and nucleated cells were counted and examined for viability by trypan blue exclusion. 
Peritoneal exudate cells (PEC):  A midventral skin incision exposed the intact peritoneum. 
The peritoneal cavity was entered with a 22 gauge needle, and 5 ml of PBS-FCS plus 5 units/ml 
sodium heparin (Upjohn Co., Kalamazoo, Mich.) were injected. The abdomen was  vigorously 
massaged to effect mixing and  the fluid content withdrawn by syringe. The above procedure 
was repeated once. The recovered suspension was passed through a double thickness of cotton 
gauze to remove clumps, and the remaining cells were washed with PBS-FCS by  centrifuga- 
tion at 200 g for 10  rain. 
Nonadherent peritoneal exudate cells (nonadherent PEC):  About 50-100 X  106 PEC in  10 
ml medium (RPMI or PBS-FCS) were loaded onto a  15 x  120 mm nylon wool column  and 
incubated for 30 rain at 37°C  (9). The nonadherent cells were eluted with excess medium and 
washed. 
Spleen cells:  Spleens were removed and placed in cold PBS-FCS, minced, pressed through 
a fine nylon mesh, filtered through cotton gauze, and washed twice. 
Peyer's  patches, thymus,  and  lymph node cells:  Lymph nodes  (cervical, axillary,  mesen- 
teric, inguinal), thymus, and Peyer's patches were collected into cold PBS-FCS and teased 
apart with fine forceps. The cell suspensions were allowed to stand to remove large clumps. 
Blood leukocytes:  Mice  were  bled from  the  retroorbital sinus into heparin.  The  whole 
blood was diluted 1:4 in PBS, further diluted 1:2 with Plasmagel (Laboratoire Roger Bellon, 
Neuilly, France), and allowed to sediment at room temperature for 2040 min. The leukocyte- 
rich supernatant was removed, spun at 200 g for 10 min, and washed in PBS-FCS. 
In Vitro Assessment of Tumor Cell Lysis.--The in vitro lysis of tumor cells was determined 
by incubating 51Cr-labeled tumor ceils with sensitized lymphoid cells and determining the 
amount of 51Cr released into the medium. The principles of this procedure have been previ- 
ously described (10-12). Tumor cells to be used as target cells were removed from the peri- 
toneal cavity of syngeneic hosts by syringe, washed in cold PBS-FCS, and adjusted to a con- 
centration of 3  X  l0  T cells/ml. 1 ml of tumor suspension was incubated with 100 ~Ci (51Cr) 
Na2CrO4 (Amersham/Searle Corp., Arlington Heights, Ill.) for 45 min at 37°C with occasional 
shaking. At the end of the labeling period, the cells were washed twice with 45 ml PBS-FCS 
and recounted.  Usually 95-100% of the labeled cells were recovered.  5  X  104  ~lCr-labeled 
tumor cells were then mixed with varying numbers of lymphoid cells in 1 ml aliquots and 
plated  in 35  mm  tissue  culture  plates  (Falcon Plastics,  Oxnard,  Calif.).  The  plates were 
incubated on a Rocker Platform (Bellco Glass, Inc., Vineland, N. J.) at 5 cycles/rain at 37°C 
in an humidified atmosphere of 5% COs in air. In those experiments with PBS-FCS as the 
sole medium, CO2 was omitted. At the end of the incubation period, 1 ml cold PBS-FCS was 
added to each plate and the contents transferred to 12 x 75 mm plastic tubes by suction. The 
tubes were centrifuged in the cold at 900 g for 10 min and the radioactivity of the supernatants 
assayed  in  a  well-type  gamma  scintillation  counter  (Baird-Atomic  Spectrometer,  Baird- 
All tissue culture reagents were from Grand Island Biological Co.. Grand Island. N. Y. 1336  IN  VITRO STUDIES ON  TUMOR TRANSPLANTATION IMMUNITY 
Atomic, Inc., Cambridge,  Mass.).  In order to determine the maximum amount of releasable 
radioactivity, labeled tumor cells were frozen and thawed three times in 0.05 1,~ NaC1, centri- 
fuged, and the radioactivity  of the supernatant assayed. The supernatant radioactivity of the 
frozen and thawed tumor cells represented 90-95% of the total radioactivity  incorporated into 
the labeled cells. 
The lysis of tumor cells by immune lymphoid cells was assayed in triplicate. The relative 
standard error of the mean of released radioactivity  seldom exceeded 3%. Variability  between 
repeat experiments on different days was no greater than +15c-/o. Results are expressed either 
as the per cent of chromium  released or as the degree of lysis, given as a per cent, according 
to the following equations: 
Counts per minute released by tumor in presence 
of immune cells 
Chromium released =  X  100.  (1) 
(as per cent)  Counts per minute released by freeze-thawed 
tumor cells 
Degree of lysis 
(as per cent) 
/Counts per minute releasedN  /Counts per minute released'~ 
[  by tumor in presence of  ]--[  by tumor in absence of 
=  \  immune cells  /  \  immune cells  /  X  100.  (2) 
Counts per minute released by freeze-thawed 
tumor cells 
We have shown elsewhere that 51Cr release correlates with trypan blue uptake. 3 
RESULTS 
In  Vitro  Cytolytic  Reactivity  and  Specificity  of  Different  Immune  Cell 
Populations.--BALB/c  mice were inoculated  intraperitoneally with  3  X  107 
EL4 cells. 10 days later, cells from the thynms, lymph nodes, Peyer's patches, 
spleen,  blood,  and  peritoneal cavity were  compared for  their cytolytic effect 
against  5~Cr-labeled EL4  cells. Results, summarizing several experiments,  are 
expressed graphically in Fig. 1. It is apparent that, in animals immunized by the 
intraperitoneal route, the greatest specific activity is given by the PEC. Lymph 
nodes,  Peyer's patch,  thymus,  and spleen cells were relatively inefficient, and 
even blood leukocytes fell considerably short of the killing produced by PEC. 
In order to see if the high cytolytic reactivity observed for PEC  was due to 
the intraperitoneal route of administration, or if tumor given elsewhere would 
elicit high reactivity in the PEC,  animals were inoculated subcutaneously with 
tumor. A  total of 3  M  107 EL4 cells was injected at multiple sites over the ab- 
dominal wall. When the PEC  were examined 10 days later, very low cytolytic 
reactivity was found  (Fig. 2).  Spleen and peripheral blood leukocytes  on the 
other hand, exhibited reactivity comparable to that found in animals sensitized 
intraperitoneally. Interestingly, the cell composition of the PEC after subcuta- 
neous  immunization differed from  normal  PEC  or PEC  obtained after intra- 
a Sullivan, K., G. Berke, and D. B. Amos. 1972. 51Or leakage  from  and  uptake  of trypan 
blue by target cells undergoing cell mediated destruction.  Transplantation. In press. GIDEON  BERKE~  KAREN  A.  SULLIVAN~  AND  BERNARD  AMOS  1337 
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FIG. 1.  51Cr release  from labeled EL4 cells incubated with BALB/c cells immune to EL4. 
Sensitized cells from the indicated sources  were mixed with ~lCr-labeled EL4 cells in RPMI 
at a  10:1  ratio  and incubated with rocking for  2.5 hr. Values given are  the means of three 
replicate cultures. Vertical bars indicate ranges. 
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Fla.  2.  Cytolytic  reactivity  of  immune lymphoid cells  from different  sources  after  sub- 
cutaneous  injection  of EL4.  Immune BALB/c  spleen  cells  (.),  blood  leukocytes  (A),  and 
PEC  (0)  were mixed with 51Cr-labeled  EL4 in PBS-FCS,  rocked for  2 hr at 37°C, and the 
per  cent  of  SlCr  released  determined.  Values are  means of  triplicate  cultures;  vertical bars 
indicate ranges. 
peritoneal  injection  (see  also  Table III).  40 %  of the  cells  recovered  were  large 
pyroninophilic  lymphoid cells;  50%  were small-  to  medium-sized lymphocytes, 
and the few remaining  cells were  mast cells,  polymorphonuclear  leukocytes,  or 
were  unidentified.  Only  a  few  macrophages  were  observed  in more  than  5000 1338  IN  VITRO  STUDIES  ON  TUMOR  TRANSPLANTATION  IMMUNITY 
cells examined.  The  total number  of PEC  recovered per mouse  was  approxi- 
mately 7  >(  106, as compared with 2-3 )<  106 for normal BALB/c mice. It was 
concluded, therefore, that the high cytolytic reactivity of the PEC  after intra- 
peritoneal inoculation (Fig. 1) was caused by localization of effector cells at the 
site of tumor rejection. 
Experiments were designed to see if the cytolytic reaction was specific or if 
chromium  would  also be released from  third-party or bystander cells. Spleen 
cells from BALB/c immunized intraperitoneally against EL4 were preincubated 
with unlabeled EL4 or SaI cells for 2 hr,  after which labeled SaI or EL4  cells 
TABLE  I 
Specificity  of Target Cell Destruction In Vitro 
Preincubation  target*  Indicator  target 
Degree of lysis 
BALB/c anti-  C57BL/6J anti-  BALB/c anti- 
EL4 spleen  SaI spleen  EL4 PEC 
%  %  %~ 
EL4  EL4§  49.6tl  0. I II  -- 
EL4  SaI§  0  27.4  -- 
SaI  EL4§  46.1  0.3  -- 
SaI  SaI§  0  26.4  -- 
--  EL4 +  SaI§  0.4  29.1  0.2 
--  SaI +  EL4§  46.5  0  75.8 
--  EL4§  48.3  0  83.1 
--  SaI§  0.3  29.5  2.4 
--  EL4 +  EL4§  --  --  77.0 
--  L1210§  --  --  0 
* 50 )< 103 tumor cells and 5 X  106 spleen cells were preincubated for 2 hr in 1 ml aliquots 
before  50  )<  103 indicator cells were added. Where preincubation was  not done,  5  )<  106 
spleen cells were added to 50 >( I08 of each indicator target cell. 
:~ The ratio of PEC to indicator cells was 20:1 and the degree of lysis was determined after 
2.5 hr of incubation. 
§ 51Cr-labeled tumor cells. 
][ Degree of lysis was determined after 4 hr incubation; values given are means  of  tripli- 
cates. 
were added. While there was no release of label from SaI, there was good release 
from EL4 (Table I). In another series, spleen cells from C57BL/6 mice, immune 
to SaI and preincubated with unlabeled SaI or EL4, released label from subse- 
quently added SaI but not from EL4. When both EL4 and SaI cells were added 
simultaneously with only one cell type labeled, specific lysis was again observed. 
In each case, the cytolytic capacity of the immune cells was demonstrated by 
their ability to release label from the  appropriate target.  Preincubation made 
the nonspecific  participation of  soluble  substances  formed  by  the  killer cells 
unlikely under the conditions of these experiments (13, 11). Comparable results 
(Table I)  were obtained if PEC  were substituted for spleen cells, or if L1210 
was substituted for SaI. GIDEON  BERKE,  KAREN  A.  SULLIVAN,  AND  BERNARD  AMOS  1339 
Adherent vs. Nonadherent PEC in the In  Vitro Destruction of Tumor Cells.- 
Crude  PEC  suspensions obtained from BALB/c immunized intraperitoneally 
against  EL4  contained  macrophages  and  lymphocytes,  Since  PEC  were  so 
efficient in target cell destruction (Fig. 1), the reactivity of the two constituent 
cell types was compared. Aliquots containing 1 M 106 PEC in 1 rnl RPMI were 
placed in 35 mm polystyrene Petri dishes and rocked at 37°C for 90 min. The 
medium phase was removed to provide nonadherent  cells, and the plates were 
washed  twice with  medium to  remove any further  nonadherent  cells.  Other 
plates were rocked and  the  cells left undisturbed.  Finally,  nonadherent  cells 
were added back to some of the washed plates to give a reconstituted PEC sus- 
pension.  Concomitant  experiments,  designed  to  test  whether  the  release  of 
conditioning substances into the medium affected the behavior of the separated 
TABLE  II 
Cytolytic A ctivity of Adherent and Nonadherent BA LB/c A nti-EL4 PEC 
Cells  Medium* 
Degree of lysis (hr) 
1  2 
%  % 
Undisturbed  Old  50.7 ~  76.8 
Nonadherent  Old  47.0  64.7 
Fresh  42.1  68.1 
Adherent  Old  7.8  20.3 
Fresh  9.8  21.3 
Reconstituted  Old  52.3  73.8 
Fresh  51.6  76.3 
* See text. 
Values given are means of triplicates. 
subpopulations, were also performed. Medium removed with nonadherent cells 
was saved. The cells were then brought to their aliquot concentration either in 
this  (old)  medium  or  in  fresh  medium  and  examined  for their  lytic  activity 
against 51Cr-labeled EL4 cells.  The results are expressed in Table II. Clearly, 
most of the activity resided in the nonadherent population. Although there were 
fewer nonadherent  cells,  the  degree of lysis approached  that  obtained in  the 
undisturbed  or reconstituted plates, while the level of killing by the adherent 
cells was correspondingly low. The relatively inefficient lysis by the  adherent 
population was not affected by restoration of the original medium, nor was the 
effectiveness of the nonadherent cells influenced by changing the medium. 
Quantitative  Aspects  of  In  Vitro  Cytotoxicity  by  Nonadherent  PEC.--The 
preceding  experiments indicated  that  cells  nonadherent  to  polystyrene  were 
effective in target cell lysis. In order to obtain a better separation, nonadherent 
PEC from immunized mice were eluted from nylon wool columns. Microscopic 
examination revealed that less than 4 % of the eluted cells had macrophage-like 1340  IN  VITRO STUDIES  ON  TUMOR TRANSPLANTATION  IMMUNITY 
characteristics  as determined by morphology and by yeast particle ingestion. 
The vast majority of cells were small- to medium-sized lymphocytes; the  re- 
maining cells were large lymphoid,  polymorphonuclear,  mast,  or unidentified 
(Table III). Although only two mitotic figures were seen in over 5000 cells ex- 
amined, data given in Table III demonstrate increased thymidine-3H incorpora- 
tion. 
A detailed kinetic analysis of target cell destruction provided information on 
the rate of killing. Nonadherent immune PEC were serially diluted and mixed 
with 5  X  104 stCr-labeled EL4 cells. The mixtures were plated and rocked and 
the per cent of 5~Cr released determined at various time intervals.  The results 
Cells 
]'ABLE  III 
BALB/c PEC Morphology and N.ucleotide Incorporation 
Cell type*  Incorporation:[: 
Lymphoid 
Polymorpho-  Thymi-  Histiocytes  nuclear  Other  Uridine-SH  Small-  Large  dine-~H 
medium 
Immune crude PEC 
Immune nonadherent 
PEC 
Normal PEC 
%  %  %  %  %  cpm  cpm 
38  <1  47  5  9  --  -- 
91  <2  2  2  3  1350  11,170 
60  3  31  3  4  2500  2040 
* Differentials were  done on  cover  slip  films  stained with  Wright's  or  Giemsa.  Total 
number of cells examined =  5073. 
:~ I  ~Ci  of uridine-3H  (20  Ci/mM)  or  thymidine-3H  (3  Ci/mM) 4 was added to  1  X  106 
cells, plated, and rocked for 2 hr at 37°C. After incubation, the cells were washed three times 
with PBS, solubilized  with  NCS solubilizer, 5 and  counted  (toluene  base scintillation solu- 
tion) in a  Packard Tri-Carb  (Packard Instrument Co., Downers Grove,  ILL). 96%  of  the 
incorporated radioactivity was found to be in acid  (10% cold trichloroacetic acid)-insolu- 
ble material. 
(Fig. 3) indicate that lysis reached a maximum rate very shortly after mixing, 6 
and was strictly dependent on the killer-to-target cell ratio. The time taken to 
reach completion was a function of the number of killer cells. 
Using a similar kinetic approach, target cell destruction by nonadherent PEC 
was compared with the  destruction  produced by crude PEC  and spleen cells. 
The data, expressed both as per cent chromium released per hour and as a func- 
tion of the ratio of immune cells to target  cells,  are given in Table IV.  From 
these results, the high efficiency of nonadherent PEC  in killing is  established 
on a  per cell basis. At a  5:1  immune,to-target cell ratio, values of 48,  22,  and 
4 Schwarz BioResearch Inc., Orangeburg, N. Y. 
5 Amersham/Searle  Corp. 
6 With the present technique employed for the determination of 51Cr release,  time meas- 
urements shorter than 45 rain are impractical. GIDEON  BERKE,  KAREN  A.  SULLIVAN,  AND  BERNARD  AMOS  1341 
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FIG. 3.  Time-course of chromium release from EL4 cells incubated with nonadherent PEC 
from immune BALB/c mice. Values given are means of triplicate cultures; vertical bars indi- 
cate ranges. Numbers indicate killer-to-target  cell ratios. 
TABLE IV 
Rate of Cytolysis of alCr-labeled EL4 by BALB/c Anti-EL4 Immune Cells 
Immune:  target ratio 
Chromium release* 
Nonadherent PEC  Crude PEC  Spleen 
%/hr  %/hr  ~,/hr 
0:1  2.7  3.3  3.0 
1:1  23.1  10.0  3.2 
5:1  48.4  22.5  5.1 
10:1  60.0  30.0  7.8 
25:1  --  42.7  9.5 
50:1  --  44.7  17.5 
100:1  --  --  30.2 
* Chromium  release was determined after 1 hr incubation; the given values are means of 
triplicates. 
5 %  label released per hour were obtained with nonadherent PEC,  crude PEC, 
and spleen cells respectively. 
The Requirement for Serum in the Cylolytic Reaction.--In this system, signifi- 
cant killing can be obtained in a very short time; because of this, it was possible 
to examine components required in the medium. Examination of various types 
of media,  including Eagle's minimal essential medium  (MEM),  RPMI  1640, 
Medium-199,  Dulbecco's modified MEM,  Hanks'  balanced salt solution,  and 1342  IN  VITRO  STUDIES  ON  TUMOR  TRANSPLANTATION  IMMUNITY 
PBS,  have shown  that  optimal lysis can be  obtained with  a  simple medium, 
provided it is supplemented with heat-inactivated fetal calf serum. Additional 
experiments using PBS supplemented with human, horse, mule, rabbit, sheep, 
and rat serum gave results similar to those obtained with fetal calf serum (Table 
V). Guinea pig serum and sera from several mouse strains were less supportive. 
Since complex media also require serum to support the killing reaction, it seemed 
possible that the limiting factor for lysis was in the added serum. The extent of 
lysis of EL4 by BALB/c anti-EL4 nonadherent PEC was, therefore, determined 
as a function of the concentration of serum and other proteins. Results of seven 
separate experiments (Fig. 4)  demonstrate that  the cytolytic reaction was in- 
deed  dependent  on  serum  concentration.  Similar  results  were  obtained  when 
FCS, extensively dialyzed against PBS, was used instead of whole serum. Bo- 
vine  serum  albumin,  human  transferrin,  bovine  gamma  globulin,  human 
albumin, ovalbumin, and sheep gamma globulin did not support the cytolytic 
TABLE  V 
Effect of Sera from  Various Sources  on  the Cytolytic Reaction 
Serum* 
FCS  Human  Rat  Rb~b" Sheep  Mule  Aghaomsma-lGuinea  pig 
Per cent ~Cr  ~  8217-  66.3  ~  81~9.9 "~Z  62~,0  47.,3 
rel° sed   I  I  J  I  /  I  I  i 
Mouse 
BALB/c] C3H/  C57/f  C57BL/spr 
Z  Z--  45.3  56.0 
* Heated at 56°C for 1 hr and used at 10% in PBS. 
~lCr released was determined after 60 miu of incubation at a 2:1  ratio of immune nonadherent PEC to EL4 
target. 
reaction. To rule out the possibility that the fetal calf serum was contributing 
heat-labile  components,  the  serum was heated  at  56°C  for  1 hr  immediately 
before use.  There  was  no  loss  of  activity.  The  addition  of carrageenin  or  of 
cobra venom factor also failed to reduce the extent of killing. 
Since  the  killing  activity was highly  dependent  upon serum concentration, 
experiments to see if the essential serum component was consumed during cyto- 
toxic  reactivity were  carried  out.  BALB/c  anti-EL4  nonadherent  PEC  were 
rocked at 37°C with unlabeled EL4 cells in PBS containing limiting concentra- 
tions  of heat-inactivated  FCS.  At  the  end  of the  incubation,  the  suspensions 
were collected, centrifuged, and the media saved. Controls were prepared in the 
same way from media that  had been incubated  with  EL4  cells,  nonadherent 
PEC,  or crude PEC  alone,  or which had  been incubated  without  added  cells 
(medium control). The media from the various groups were serially diluted and 
examined for their capacity to support the killing of ~lCr-labeled EL4 cells by a 
fresh preparation of immune nonadherent PEC. The results (Fig. 5), summariz- 
ing  three  separate  experiments,  showed  that  medium  which  had  previously GIDEON  BERKE~  KAREN  A.  SULLIVAN,  AND  BERNARD  AMOS  1343 
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FCS  IN  PBS  DURING CYTOLYSIS 
FIG.  5.  Consumption of  medium  components during the cytolytic reaction of  BALB/c 
anti-EL4 nonadherent PEC against EL4 tumor cells. The results are expressed as the per cent 
of chromium release obtained with the various media minus the per cent of chromium release 
obtained with media preincubated without cells plotted against the concentration of FCS in 
PBS employed during the subsequent cytolytic reaction. PBS containing 8, 4, or 3% FCS was 
preincubated with  EL4  (O),  immune  nonadherent PEC  (O),  immune  nonadherent PEC 
plus EL4  (A), or immune crude PEC  (A) for 60-120 rain at 37°C  with rocking. Killer-to- 
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supported cytotoxicity remained supportive even when the included serum was 
at very low concentration. In this figure, values above the horizontal line repre- 
sent increased lysis after incubation with effector cells and target; values below 
the line show decreased efficiency. The random scatter and the over-all closeness 
to the control value show  there  was neither increased nor decreased  activity. 
E~ects of  Trypsin  Treatment,  Freeze-Thawing,  and  Homogenization  of PEC 
on Their Killing Activity.--The experiments to this point have shown that the 
Experi- 
ment 
TABLE VI 
Effect of Trypsin Treatment on Killing Reactivity 
Chromium release  (rain); 
Cells  Serum* 
45  6O  90  120  150 
% 
Crude immune PEC§  IMS  3.8  10.0 
NMS  3.7  14.5 
Normal PEC §  IMS  2.6  5.2 
NMS  2.0  3.5 
Crude immune PEC  FCS  35.9  73.9 
Normal PEC  FCS  3.2  3.9 
24.0 
38.1 
7.5 
6.2 
95.2 
6.2 
2  Nonadherent  immune  IMS  11.3  27.2 
PEC§  NMS  12.0  23.7 
FCS  11.0  27.2 
Nonadherent  immune  IMS  38.8  70.4 
PEC  NMS  32.6  58.8 
FCS  41.9  71.3 
* Cells were incubated  after  treatment  with  either  trypsin  or  PBS-FCS  for  30  min  at 
37°C in immune BALB/c anti-EL4 serum with a cytotoxic titer against EL4 of 1/512 (IMS), 
normal BALB/c serum  (NMS), or FCS; all sera were diluted  1:2 in PBS. 
PEC to target cell ratio  10:1. Values are means of triplicates. 
§ Trypsin-treated  cells. Experiment  1:5 X  106 normal or immune crude PEC incubated 
for  30  min at 37°C in a  5 mg/ml trypsin  (Worthington)  solution  in PBS.  Experiment  2: 
12  X  106 nonadherent  PEC incubated  for 30 rain at 37°C in a 3 mg/ml trypsin  solution in 
PBS. All cells were washed three  times with  PBS-FCS after trypsin  treatment.  Nontrypsin- 
treated cells were incubated  in PBS-FCS. 
killing effect is specific, potent,  largely due  to  the nonadherent  cells,  and  de- 
pendent  on  the  concentration  of FCS.  Experiments were  undertaken  to  in- 
vestigate whether killing was related to the presence of a trypsin-sensitive cell- 
bound antibody (7). Nonadherent PEC or crude PEC were treated with trypsin, 
washed,  and left to recover in  the  presence of a  hyperimmune BALB/c anti- 
EL4 serum,  normal BALB/c serum,  or fetal calf serum.  At the end of the re- 
covery period,  the  cells were washed  and  their  ability to  damage  target  cells 
was measured. The results of these experiments (Table VI) showed that PEC, 
either nonadherent or crude, when treated with trypsin, temporarily lost much GIDEON BERKE, KAREN A.  SULLIVAN, AND  BERNARD AMOS  1345 
of their cytolytic power (14) although 95 %  of the treated cells excluded trypan 
blue. Activity returned  with time; the regeneration of activity occurred in the 
presence of FCS just as well as it did in immune or in normal BALB/c serum. 
These experiments do not support the notion that the high reactivity found in 
this  system is  due  to  a  trypsin-sensitive,  cell-bound  antibody similar  to  that 
described for macrophage-mediated cytolysis (7). 
Experiments  were  performed  to  determine  whether  a  cell-free  lysate  made 
from killer cells,  or medium obtained from a culture where lysis had occurred, 
would  affect  51Cr-labeled  target  cells.  A  suspension  of nonadherent  BALB/c 
anti-EL4 PEC was divided into aliquots. The first was frozen and thawed three 
TABLE VII 
Cytolytic  Effect on  ~lCr-labeled EL4 of Cell-Free Preparations  Made from Nonadherent  PEC 
Group  Relative concentration  Degree of lysis 
% 
Freeze-thaw  1  : 2*  0.5:~ 
Homogenate  1 : 2"  0.0 
Medium  1 : 1§  0.7 
1:2  1.2 
1:4  0.6 
PEC  5:111  92.2 
1:1  33.7 
0.5:1  17.5 
* Preparations  were made from 15 X  106 PEC in 2 ml PBS-FCS and diluted in PBS-FCS. 
:~ Degree of lysis was determined after 90 min of incubation from triplicate cultures. 
§ Dilution  in PBS-FCS  of medium  (PBS-FCS)  collected from a  cytolytic culture  incu- 
bated for 90 min with rocking which had a killer-to-target cell ratio of 10:1. 
[] Values refer to killer-to-target  cell ratio. 
times; the second was homogenized by 20 strokes in a Teflon-glass homogenizer; 
the  third  was preincubated  with  unlabeled  EL4 cells.  The supernatants  were 
examined  for their  effects on EL4  cells.  There  was  no evidence  of a  cell-free 
constituent  capable  of destroying target  cells  (Table  VII).  Control  cells  de- 
rived from the same starting material and held on ice were fully active. 
DISCUSSION 
The  identity  of the  specific  cell  type(s)  responsible  for cell-mediated  graft 
rejection  is  an  unsettled  question.  However,  specifically  sensitized  lymphoid 
cells have been shown to function in the immunological rejection of homografts 
(15) and to mediate, in vitro, a direct cytotoxic reaction upon target cells genet- 
ically  similar  to  the  tissue  used  for  immunization  (16,  17).  Thoracic 1346  IN  VITRO  STUDIES  ON  TUMOR  TRANSPLANTATION ILMMUNITY 
duct lymphocytes injected into histoincompatibte recipients soon develop into 
large pyroninophilic cells in the afferent phase of cellular responsiveness. These 
cells  undergo  mitosis  yielding  small-  and  medium-sized  lymphocytes  (18). 
Ginsburg (19) and Denham et al. (20) have implicated a large lymphoid cell as 
the  effector of  cell-mediated  immunity,  while  Weiner's  electron microscope 
studies (21) have associated a ribosome-rich small lymphocyte with damage to 
grafted tissue. 
Effector cells used in cytotoxicity tests are generally derived from spleen or 
lymph nodes of immune animals. Such conventional lymphoid cell preparations 
undoubtedly contain a large number of irrelevant cells.  Attempts to obtain a 
specifically immune effector cell population by using draining lymph nodes (22) 
m'  cellular  immunoabsorbents  (23,  24)  have  been  only  partially  successful. 
Ideally, one would like to study those effector cells anatomically associated with 
a~ rejected graft. While this is technically difficult with solid grafts, the use of an 
allotransplanted  ascites  tumor  provides,  in  readily  accessible  suspension,  a 
unique population of effector cells capable of causing a vigorous destruction of 
appropriate target cells in vitro. This source of effector cells has received sur- 
prisingly little attention. Early experiments with PEC concentrated on macro- 
phages (6, 7). Recently, however, Takasugi and Klein (25)  have described the 
efficacy of crude PEC  in target cell destruction.  Oppenheimet  al.  (26)  have 
shown that PEC, induced by mineral oil, from guinea pigs sensitized by intra- 
dermal inoculations depressed the uptake of tritiated thymidine by tumor cells. 
We have found that shortty after the disappearance of EL4 ascites tumor 
from BALB/c mice a population of nonadherent PEC appears which is uniquely 
potent in the in vitro destruction of EL4 cells. These cells provide an avenue for 
the characterization of at least one type of effector cell  and may, because of 
their unusual potency, allow more complete studies on the mechanism of cell- 
mediated allograft destruction. The cells appear to be almost exclusively small- 
to  medium-sized  lymphocytes. They  are  intensely pyroninophilic and,  with 
Wright's stain, have densely basophilic nuclei with pale blue rims of cytoplasm. 
Examination of over 5000 ceils revealed no more than two mitotic figures. It 
should be noted, however, that this population of effector cells is capable of a 
fivefold increase in the incorporation of tritiated thymidine as compared with 
normal PEC. The role of the macrophage as the major effector cell in this system 
could be excluded. The efficiency of killing,  on a  per cell basis,  was increased 
rather than diminished by removal of the macrophages. The effector cells dif- 
fered in their properties from activated macrophages by regaining activity on 
incubation with normal as well as with imnmne serum after trypsin treatment 
(7). It is our belief that the cell active in this system is  a  particular kind of 
small- or medium-sized lymphoid cell and that the blastoid phase of lymphocyte 
activation (18, 27) involves the priming and programming of these cells. 
A quantitative interrelationship between the effector cells and the target cells 
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have been elucidated. We have shown that the rate of target cell destruction is 
dependent on the concentration of effector cells. It was also found to be depend- 
ent on the concentration  of target cells. ~ The unexpectedly high reactivity of 
nonadherent  PEC  is best documented in those experiments where the rate of 
target cell destruction, i. e. per cent chromium released per hour, was measured 
as a  function of killer-to-target cell ratio.  When the rates were compared for 
column-separated, nonadherent PEC, crude PEC, and spleen cells at a killer-to- 
target cell ratio of 10:1, values of 60, 30, and 8 % 51Cr released/hr, respectively, 
were obtained. The rates of EIA destruction by nonadherent PEC reported here 
are far greater than those reported where spleen or lymph node cells were em- 
ployed (28-30,  11). It seems most likely that the high efficacy of nonadherent 
PEC is due to the presence of a high proportion of effector cells at the reaction 
site. However, we are aware of a different explanation, namely, that the content 
of effector cells in PEC is similar to that of spleen or lymph nodes but that the 
mechanism of lysis produced by them is  different. This possibility seems un- 
likely. Particular features of target cell destruction by spleen and other lymph- 
oid cells are shared by PEC.  The findings that  the reaction is specific and is 
produced by viable sensitized lymphoid cells, their sensitivity to trypsin and 
subsequent  recovery in  normal serum,  together with  the  demonstration  that 
target cell lysis is initiated shortly after mixing and proceeds with a rate depend- 
ent on both effector and target cell concentration, are examples of the similarity 
(28-30,  11).  We conclude that the effects of PEC and those of lymphoid cells 
from other sources are qualitatively similar but quantitatively different. 
The  dependence  of the  cytolytic reaction  on  serum concentration  and  the 
observation  that  optimal  reactivity  can  be  obtained  in  phosphate-buffered 
saline supplemented with serum of any of a variety of species suggests that a 
serum component(s) is engaged in the reaction. Bovine serum albumin or human 
transferrin, as well as several other purified proteins, could not replace serum, 
nor could the combination of FCS dialyzate and bovine serum albumin. Heated 
serum (56°C for 1 hr)  was as good as unheated serum, and serum extensively 
dialyzed against PBS was fully supportive. It is interesting that the serum com- 
ponent(s) is not exhausted by the reaction, suggesting a possible catalytic func- 
tion. 
The poor cytolytic activity of peritoneal cells obtained,  without the admin- 
istration of irritants, from animals injected subcutaneously with EL4 supports 
our concept of effector cell accumulation at the site of allograft rejection. These 
PEC  produced little tumor cell lysis even at a  50-fold ratio of PEC  to target 
cells.  Target cell destruction by spleen and blood leukocytes from these same 
animals  was  as  expected.  These  experiments  offer an  interesting  contrast  to 
7 Berke, G., K. A. Sullivan, and D. B. Amos. Rejection of ascites tumor allografts. II. A 
pathway of cell-mediated destruction in vitro by peritoneal exudate effector cells. Manuscript 
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those in which lysis was obtained at less than one PEC per target  cell when the 
tumor had been rejected in the peritoneal cavity. 
SUMMARY 
Peritoneal  exudate  cells  (PEC),  obtained  after  the  rejection  of  EL4 
leukemia  by BALB/c  mice,  are  much  more effective in the specific in vitro 
destruction  of ~lCr-labeled EL4 cells than are spleen,  thymus, lymph node,  or 
peripheral  blood lymphocytes. The presence of a  large number of effector cells 
at the site of graft rejection is reflected in the potent cytolytic activity seen in 
vitro.  Effector  cells  temporarily  lose  cytolytic  reactivity  when  treated  with 
trypsin but regain reactivity with time. This recovery occurs in normal as well 
as  in  immune  serum.  The  destructive  reactivity  of  PEC  is  increased 
when  macrophages  are  removed.  The  remaining  population  of  nonadherent 
PEC is composed primarily of small- to medium-sized lymphocytes. Complex 
tissue  culture media  are  not  needed,  but  there  is  a  definite  requirement  for 
serum. The required serum component is heat stable,  nondialyzable, and is not 
consumed during the reaction. The use of an ascites allograff system made these 
observations possible and permitted the isolation of those host cells intimately 
associated with rejection. 
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